LIR: LC3 interacting region
Ongoing Monitoring Schedule | Timepoint | Assessment | |---|---| | Week 0 (baseline) | Labs listed above
Park AM, Khan S, Rawnsley J
Slowing the ramp to the label cadence (2.5 mg start, 2.5 mg steps, four-week holds) dropped that to mid-single digits at every maintenance dose, at no cost to the 12-week result, and the dedicated slow-titration trial reached placebo range. Reaching 15 mg is not the problem
This luxurious soap gently cleanses while effectively brightening and evening your skin tone, diminishing the appearance of dark spots and hyperpigmentation
If a peptide has any role, it is one part of a supervised plan, not a shortcut around the basics